Halogen Bond: Its Role beyond Drug-Target Binding Affinity for Drug Discovery and Development
文献类型：期刊论文
| 作者 | Xu, Zhijian1 ; Yang, Zhuo1; Liu, Yingtao1; Lu, Yunxiang2; Chen, Kaixian1; Zhu, Weiliang1
|
| 刊名 | JOURNAL OF CHEMICAL INFORMATION AND MODELING
 |
| 出版日期 | 2014-01 |
| 卷号 | 54期号:1页码:69-78 |
| ISSN号 | 1549-9596 |
| DOI | 10.1021/ci400539q |
| 文献子类 | Article |
| 英文摘要 | Halogen bond has attracted a great deal of attention in the past years for hit-to-lead-to-candidate optimization aiming at improving drug-target binding affinity. In general, heavy organohalogens (i.e., organochlorines, organobromines, and organoiodines) are capable of forming halogen bonds while organofluorines are not. In order to explore the possible roles that halogen bonds could play beyond improving binding affinity, we performed a detailed database survey and quantum chemistry calculation with close attention paid to (1) the change of the ratio of heavy organohalogens to organofluorines along the drug discovery and development process and (2) the halogen bonds between organohalogens and nonbiopolymers or nontarget biopolymers. Our database survey revealed that (1) an obviously increasing trend of the ratio of heavy organohalogens to organofluorines was observed along the drug discovery and development process, illustrating that more organofluorines are worn and eliminated than heavy organohalogens during the process, suggesting that heavy halogens with the capability of forming halogen bonds should have priority for lead optimization; and (2) more than 16% of the halogen bonds in PDB are formed between organohalogens and water, and nearly 20% of the halogen bonds are formed with the proteins that are involved in the ADME/T process. Our QM/MM calculations validated the contribution of the halogen bond to the binding between organohalogens and plasma transport proteins. Thus, halogen bonds could play roles not only in improving drug-target binding affinity but also in tuning ADME/T property. Therefore, we suggest that albeit halogenation is a valuable approach for improving ligand bioactivity, more attention should be paid in the future to the application of the halogen bond for ligand ADME/T property optimization. |
| WOS关键词 | RESOLUTION CRYSTAL-STRUCTURES ; NONCOVALENT INTERACTIONS ; SUPRAMOLECULAR CHEMISTRY ; DENSITY FUNCTIONALS ; RATIONAL DESIGN ; LIGAND-BINDING ; CHARGE-DENSITY ; FORCE-FIELD ; INHIBITORS ; TRANSTHYRETIN |
| 资助项目 | Ministry of Science and Technology[2012AA01A305] ; National Natural Science Foundation[81273435] ; National Natural Science Foundation[81302699] ; National Natural Science Foundation[21103047] ; Postdoctoral Science Foundation of China[2013M541568] ; State Key Laboratory of Drug Research[SIMM1203KF-01] ; State Key Laboratory of Medicinal Chemical Biology, Nankai University[20130265] |
| WOS研究方向 | Pharmacology & Pharmacy ; Chemistry ; Computer Science |
| 语种 | 英语 |
| WOS记录号 | WOS:000330542800008 |
| 出版者 | AMER CHEMICAL SOC |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/277315]  |
| 专题 | 药物发现与设计中心 中科院受体结构与功能重点实验室 新药研究国家重点实验室 |
| 通讯作者 | Lu, Yunxiang |
| 作者单位 | 1.Chinese Acad Sci, Drug Discovery & Design Ctr, Key Lab Receptor Res, State Key Lab Drug Res,Shanghai Inst Mat Med, Shanghai 201203, Peoples R China; 2.E China Univ Sci & Technol, Dept Chem, Shanghai 200237, Peoples R China |
| 推荐引用方式 GB/T 7714 | Xu, Zhijian,Yang, Zhuo,Liu, Yingtao,et al. Halogen Bond: Its Role beyond Drug-Target Binding Affinity for Drug Discovery and Development[J]. JOURNAL OF CHEMICAL INFORMATION AND MODELING,2014,54(1):69-78. |
| APA | Xu, Zhijian,Yang, Zhuo,Liu, Yingtao,Lu, Yunxiang,Chen, Kaixian,&Zhu, Weiliang.(2014).Halogen Bond: Its Role beyond Drug-Target Binding Affinity for Drug Discovery and Development.JOURNAL OF CHEMICAL INFORMATION AND MODELING,54(1),69-78. |
| MLA | Xu, Zhijian,et al."Halogen Bond: Its Role beyond Drug-Target Binding Affinity for Drug Discovery and Development".JOURNAL OF CHEMICAL INFORMATION AND MODELING 54.1(2014):69-78. |
入库方式： OAI收割
来源：上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。